ARS Pharmaceuticals Inc (NASDAQ:SPRY)
| 7.24 Delayed Data As of Jun 02 |  +0.37 / +5.39%Today’s Change | 3.38 Today|||52-Week Range 9.65 | -15.12% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Shawver Laura K Director |  Sale | 5/08/2023 | 57,100 | $6.16 | $351.7K | +20.47% |
Shawver Laura K Director | Sale | 5/09/2023 | 42,900 | $5.31 | $227.8K | +40.58% |
Shawver Laura K Director | Sale | 11/09/2022 | 43,896 | $4.58 | $201.0K | +19.47% |
Shawver Laura K Chief Executive Officer |  Buy | 8/05/2022 | 78,740 | $1.27 | $100.0K | +39.23% |
Shawver Laura K Director | Buy | 5/08/2023 | 57,100 | $1.27 | $72.5K | +20.47% |
Shawver Laura K Director | Buy | 5/09/2023 | 42,900 | $1.27 | $54.5K | +40.58% |